LCTX
Lineage Cell Therapeutics, Inc.
$1.34
+0.02 (+1.52%)
At close · Jul 8
Market Cap
$321.59M
Shares
249,298,295
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-12 | 2026-06-09 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-29 | — | |
| 8-K | 2026-03-11 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2025-11-28 | — | |
| 8-K | 2025-11-24 | 2025-11-20 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-08-26 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-07-02 | 2025-06-26 | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-06-09 | 2025-06-03 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-04-29 | 2025-06-26 | |
| 8-K | 2025-03-10 | — | |
| 10-K | 2025-03-10 | 2024-12-31 | |
| 8-K | 2025-01-27 | — | |
| DEF 14A | 2024-12-09 | — | |
| 8-K | 2024-11-20 | 2024-11-19 | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-14 | 2024-06-11 | |
| 8-K | 2024-06-13 | 2024-06-11 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-29 | 2024-06-11 | |
| 8-K | 2024-03-22 | 2024-03-12 | |
| 10-K | 2024-03-07 | 2023-12-31 | |
| 8-K | 2024-03-07 | — | |
| 8-K | 2024-02-15 | 2024-02-14 | |
| 8-K | 2024-02-06 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-09-07 | 2023-09-06 | |
| 8-K | 2023-08-10 | — | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| DEF 14A | 2023-07-27 | — | |
| 8-K | 2023-06-21 | — | |
| 8-K | 2023-05-18 | — |
Showing 1–50 of 115 filings